4649-27-8 Usage
General Description
1,3-Dioxo-2-phenylisoindoline-5-carboxylic acid is a chemical compound with the molecular formula C16H9NO5. It is a heterocyclic compound that contains both a carboxylic acid and a phenyl group. 1,3-DIOXO-2-PHENYLISOINDOLINE-5-CARBOXYLIC ACID has potential applications in organic synthesis and drug discovery due to its unique structure and properties. It can be used as a building block for the synthesis of various organic molecules and may also exhibit biological activity that could be useful in the development of new pharmaceuticals. Further research is needed to fully understand the potential uses and properties of 1,3-Dioxo-2-phenylisoindoline-5-carboxylic acid.
Check Digit Verification of cas no
The CAS Registry Mumber 4649-27-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,6,4 and 9 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 4649-27:
(6*4)+(5*6)+(4*4)+(3*9)+(2*2)+(1*7)=108
108 % 10 = 8
So 4649-27-8 is a valid CAS Registry Number.
InChI:InChI=1/C15H9NO4/c17-13-11-7-6-9(15(19)20)8-12(11)14(18)16(13)10-4-2-1-3-5-10/h1-8H,(H,19,20)
4649-27-8Relevant articles and documents
NEW PLASMA LIPID LOWERING AGENTS
-
Page/Page column 21; 22; 45; 51; 56, (2015/12/24)
The present invention relates to new plasma lipid lowering compounds and pharmacological compositions,and their use in the prophylaxis, prevention and treatment of hyperlipidemia, including hypertriglyceridemia, hyperlipoproteinemia, and hypercholesterolemia, as well as hyperlipidemia-related diseases.
An expedient method to the synthesis of N-substituted 1H-isoindole-1,3(2H)- diones
Nikpour, Farzad,Mogaddam, Baran Mohammadi
experimental part, p. 2289 - 2292 (2011/04/17)
The synthesis of N-substituted 1H-isoindole-1,3-(2H)-diones is described from the reaction of cyclic anhydrides with Schiff bases as suitable replacing substrates instead of the corresponding amines. The Japan Institute of Heterocyclic Chemistry.
